Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults

Neuromuscular Fatigue Clinical Trial

— LENGTH-FATIG  

Official title:

Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03049241
• Other study ID #: CHU-304
• Secondary ID: 2016-A00827-44
• Status: Completed
• Phase: N/A
• First received: February 3, 2017
• Last updated: November 27, 2017
• Start date: February 13, 2017
• Est. completion date: November 20, 2017

Study information

• Verified date: November 2017
• Source: University Hospital, Clermont-Ferrand
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults.

Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.

Description:

The study of neuromuscular fatigue in children is a recently topic in the field of sport sciences. Such knowledge could improve the efficiency and security of training and rehabilitation in healthy children and children with diseases like obesity.

The LENGTH-FATIG study will provide knowledge about the peripheral and central mechanisms of the neuromuscular fatigue in children and adults. Fatigue will test for different muscle groups (knee extensors and ankle plantar flexors) at different muscle lengths (short, optimal and long).

During high-intensity exercise, prepubertal children are more resistant to fatigue than adults. Contributions of the central and peripheral components to the development of neuromuscular fatigue are also different between both populations. The reduced children's fatigue coud be particularly related to a lower peripheral (i.e. muscular) fatigue. This might be attributed to the fact that prepubertal children rely more on oxidative than anaerobic metabolism than adults during fatiguing exercise. On the other hand, nervous factors could also explain differences in fatigue between children and adults. However, this topic is scarcely documented and still controversial. To our knowledge, no study has still compared the aetiology of central fatigue (supra-spinal vs. spinal) between children and adults. Only the voluntary activation level had been studied in children, conventionally used to assess central fatigue. But this factor doesn't differentiate spinal and supra-spinal contributions to neuromuscular fatigue development.

The LENGTH-FATIG research project is a physiological and observational study comparing two age groups (adults and children). Subjects will have to perform three randomized fatigue protocols at three muscle lengths (short, optimal and long) with the knee extensors and the ankle plantar flexors.

Data will be analyzed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro-Wilk test and a Barlett test.

If normality and homogeneity of the variables are verified, absolute values of variables (Force, EMG, NIRS, etc.) will be compared using three factors (age x muscle length x muscle group) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.

If, on the contrary, normality and homogeneity of the variables are not verified, the effects of muscle length, muscle group and age will be evaluated using a Friedman test. If the tests show significant effects, comparisons of the different conditions will be performed using Mann-Whitney and Wilcoxon tests.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: November 20, 2017
• Est. primary completion date: November 20, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 8 Years to 35 Years

Eligibility

Inclusion Criteria:

• Boys aged 8 to 11 years old, Tanner stages 1 to 3

• Male aged 18 to 35 years old

• Non-smoker

• Moderate physical activity level (< 4h/week)

• Covered by a social health insurance

• Consent form signed by participants and/or legal guardians.

Exclusion Criteria:

• Competitive training

• Cardiac or pulmonary diseases

• Epileptic seizures past history

• Magnetic field contraindication (including cardiac valve, pacemaker, prosthesis material, ferro-magnetic foreign body, cochlear implant and ocular prosthesis material.

Related Conditions & MeSH terms

• Fatigue
• Neuromuscular Fatigue

Intervention

Other:
• neuromuscular fatigue
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults

Locations

Country	Name	City	State
France	CHU Clermont-Ferrand	Clermont-Ferrand

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand	Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maximal torque of knee extensors		once a week during six weeks.
Primary	ankle plantar flexors joint (in N.m) measured with a dynamometer.		once a week during six weeks.
Secondary	Doublet torque amplitude (100Hz, in N.m) evoked using magnetic nerve stimulation at rest		once a week during six weeks.
Secondary	Muscular tissue oxygenation (in µmol.L-1) measured at skin surface by Near-infrared spectroscopy.		once a week during six weeks
Secondary	Compound muscle action potential amplitude (i.e. M-wave ; in mV) evoked by supramaximal magnetic nerve stimulation and measured by surface Electromyography (EMG).		once a week during six weeks
Secondary	High frequency doublet (100Hz)/low frequency doublet (10Hz) ratio		once a week during six weeks
Secondary	fascicule length (mm) measured by B-mode real time ultrasound scanner.		once a week during six weeks
Secondary	pennation angle (degree) measured by B-mode real time ultrasound scanner.		once a week during six weeks
Secondary	Voluntary activation level (in %) assessed by using the twitch interpolation technique.		once a week during six weeks
Secondary	EMG signal Root mean square of EMG signal during isometric maximal voluntary contractions.		once a week during six weeks
Secondary	Hoffman reflex amplitude (i.e. H-reflex ; in mV) evoked by submaximal magnetic nerve stimulation measured by surface Electromyography (EMG).		once a week during six weeks
Secondary	Cerebral tissue oxygenation (in µmol.L-1) measured at skin surface by Near-infrared spectroscopy		once a week during six weeks